Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down – Time to Sell?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) shares gapped down prior to trading on Friday. The stock had previously closed at $31.63, but opened at $28.59. Kestra Medical Technologies shares last traded at $28.7750, with a volume of 6,325 shares traded.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on KMTS. Weiss Ratings raised shares of Kestra Medical Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, September 16th. Wall Street Zen downgraded shares of Kestra Medical Technologies from a “hold” rating to a “sell” rating in a report on Sunday, November 8th. Evercore started coverage on Kestra Medical Technologies in a report on Tuesday, October 20th. They issued an “outperform” rating and a $34.00 target price on the stock. Royal Bank Of Canada set a $30.00 price target on shares of Kestra Medical Technologies in a report on Tuesday, September 15th. Finally, JPMorgan Chase & Co. started coverage on Kestra Medical Technologies in a research note on Monday, August 10th. They issued an “overweight” rating and a $30.00 price objective for the company. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Kestra Medical Technologies presently has an average rating of “Moderate Buy” and an average target price of $29.00.

Kestra Medical Technologies Stock Performance

The company has a quick ratio of 4.69, a current ratio of 4.69 and a debt-to-equity ratio of 0.33. The firm has a 50 day moving average of $27.38 and a 200-day moving average of $24.12. The company has a market cap of $1.71 billion, a P/E ratio of -10.73 and a beta of 0.45.

Kestra Medical Technologies (NASDAQ:KMTS) last posted its quarterly earnings results on Monday, September 14th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.61) by ($0.14). Kestra Medical Technologies had a negative net margin of 140.43% and a negative return on equity of 63.83%. The business had revenue of $30.97 million during the quarter. As a group, sell-side analysts anticipate that Kestra Medical Technologies, Ltd. will post -2.45 EPS for the current fiscal year.

Insider Activity at Kestra Medical Technologies

In other news, insider Traci Umberger sold 30,000 shares of the firm’s stock in a transaction dated Tuesday, October 27th. The stock was sold at an average price of $30.03, for a total value of $900,900.00. Following the completion of the transaction, the insider directly owned 195,825 shares in the company, valued at $5,880,624.75. This trade represents a 13.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Brian Webster sold 15,000 shares of Kestra Medical Technologies stock in a transaction that occurred on Tuesday, October 20th. The shares were sold at an average price of $29.56, for a total transaction of $443,400.00. Following the sale, the insider owned 445,215 shares of the company’s stock, valued at approximately $13,160,555.40. The trade was a 3.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 266,456 shares of company stock worth $7,585,946 in the last quarter. 5.30% of the stock is owned by insiders.

Institutional Investors Weigh In On Kestra Medical Technologies

A number of institutional investors have recently added to or reduced their stakes in KMTS. First Trust Advisors LP increased its position in shares of Kestra Medical Technologies by 352.1% during the third quarter. First Trust Advisors LP now owns 313,012 shares of the company’s stock worth $8,855,000 after purchasing an additional 243,775 shares in the last quarter. Global Retirement Partners LLC lifted its stake in Kestra Medical Technologies by 56,300.0% during the third quarter. Global Retirement Partners LLC now owns 1,692 shares of the company’s stock worth $48,000 after purchasing an additional 1,689 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Kestra Medical Technologies during the third quarter worth $353,000. Sterling Capital Management LLC increased its position in shares of Kestra Medical Technologies by 834.0% during the third quarter. Sterling Capital Management LLC now owns 878 shares of the company’s stock worth $25,000 after acquiring an additional 784 shares during the period. Finally, Corient Private Wealth LP boosted its holdings in Kestra Medical Technologies by 284.2% in the second quarter. Corient Private Wealth LP now owns 60,614 shares of the company’s stock valued at $1,542,000 after purchasing an additional 44,839 shares during the period.

Kestra Medical Technologies Company Profile

Kestra Medical Technologies is a medical technology company focused on wearable solutions for people at risk of sudden cardiac arrest. Its products combine cardiac monitoring, treatment technology and digital services intended to support patients and their care teams. The company’s flagship product, the ASSURE wearable cardioverter defibrillator, continuously monitors a patient’s heart rhythm and can deliver a treatment shock if it detects a life-threatening arrhythmia. The system also provides alerts and supports remote sharing of patient data with clinicians.